Biological samples from nonhuman primates are now available from the National Institute on Aging (NIA) Aging Cell Repository.
The collection of nonhuman primate biomaterials available for distribution has recently been expanded to include 27 unique species, up from 10 previously. Several species have a broad representation of sex and age. A full listing of available samples can be found here:
https://www.coriell.org/1/NIA/Animal-Models-of-Aging-2/Nonhuman-Primates
These samples—including fibroblast and lymphoblastoid cell lines—are only available to academic institutions and nonprofit groups within the United States. Limitations on the numbers and type of samples may apply. They are free for researchers, but appropriate shipping fees do apply.
DNA from select samples may be added to this collection in the future.
Similar to those derived from humans, biomaterials derived from animals—such as these from nonhuman primates and others—have a unique and invaluable role in aging research and in understanding how to preserve health into old age. They provide a renewable resource for experimentation into the mechanisms of aging without the need for periodic/repeated collection from living animals.
“The NIA Aging Cell Repository is excited to be able to offer these important and unique samples to the research community. With the support of the NIA, we hope that these samples will help advance our knowledge of aging, health and disease,” said Kate Driesbaugh, PhD, Coriell’s Director of Repository Operations and the Principal Investigator of the NIA Aging Cell Repository at Coriell.
Aside from nonhuman primates, the Aging Cell Repository includes biological samples from several other mammalian species. https://www.coriell.org/1/NIA/Animal-Models-of-Aging-2/Other-Mammals
The NIA Aging Cell Repository is funded under NIH contract number 75N95020C00003-P00005-9999-1.
About the Coriell Institute for Medical Research
Founded in 1953, the Coriell Institute for Medical Research is a nonprofit research institute dedicated to improving human health through biomedical research. Coriell scientists lead research in personalized medicine, cancer biology, epigenetics, and the genomics of opioid use disorder. Coriell also hosts one of the world's leading biobanks—comprised of collections for the National Institutes of Health, disease foundations and private clients—and distributes biological samples and offers research and biobanking services to scientists around the globe. To facilitate drug discovery and disease study, the Institute also develops and distributes collections of induced pluripotent stem cells. For more information, visit Coriell.org.
